GIANNELLI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.852
EU - Europa 1.275
AS - Asia 289
AF - Africa 22
OC - Oceania 1
Totale 3.439
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.845
RU - Federazione Russa 551
IE - Irlanda 217
SE - Svezia 182
SG - Singapore 94
IT - Italia 84
HK - Hong Kong 77
UA - Ucraina 72
FI - Finlandia 57
CN - Cina 49
DE - Germania 44
TR - Turchia 39
GB - Regno Unito 31
IN - India 27
CI - Costa d'Avorio 20
CH - Svizzera 15
FR - Francia 7
CA - Canada 6
BE - Belgio 4
NL - Olanda 4
CZ - Repubblica Ceca 2
JO - Giordania 2
NO - Norvegia 2
SC - Seychelles 2
AT - Austria 1
AU - Australia 1
KR - Corea 1
MX - Messico 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 3.439
Salva come PNG Salva come JPEG
Città #
Fairfield 234
Chandler 219
Dublin 217
Ashburn 149
Woodbridge 116
Jacksonville 102
Cambridge 99
Wilmington 87
Seattle 85
Houston 81
Singapore 71
Ann Arbor 60
Princeton 56
Buffalo 50
Boardman 38
Boston 38
Izmir 38
Hong Kong 30
Mumbai 27
Altamura 26
Beijing 26
Lawrence 26
Medford 25
Abidjan 20
Shanghai 17
Norwalk 16
Bern 15
San Diego 13
Bremen 11
New York 11
Washington 11
Falls Church 10
Santa Clara 10
Hillsboro 8
Andover 6
Florence 5
Milan 5
Philadelphia 5
Salerno 5
Brussels 4
Los Angeles 4
Toronto 4
Auburn Hills 3
Casalecchio di Reno 3
Guangzhou 3
Kent 3
Laurel 3
Redmond 3
Brno 2
Dearborn 2
Frankfurt Am Main 2
London 2
Meppel 2
Munich 2
Old Bridge 2
Oslo 2
Padova 2
Tappahannock 2
Bologna 1
Central 1
Civitanova Marche 1
Clifton 1
Genoa 1
Grevenbroich 1
Groningen 1
Helsinki 1
Livorno 1
Melbourne 1
Montréal 1
Mérida 1
Napanee 1
Paris 1
Rome 1
San Mateo 1
Sanayi 1
Seoul 1
Stanford 1
Verona 1
Vienna 1
Worcester 1
Totale 2.140
Salva come PNG Salva come JPEG
Nome #
Modifications of plasma platelet-activating factor (PAF)- acetylhydrolase/PAF system activity in patients with chronic hepatitis C virus infection 126
Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation 113
Effect of chronic hepatitis C virus infection on inflammatory lipid mediators 108
COMBINED PRESENCE OF HCVRNA SEQUENCES AND T(14;18) (q32;q21) TRANSLOCATION IN PBMC FROM PATIENTS WITH CHRONIC HCV INFECTION. 99
T(14;18) translocation in chronic hepatitis C virus infection 98
Impaired response to alpha interferon in patients with an inapparent hepatitis B and hepatitis C virus coinfection 98
Association between mixed cryoglobulinemia, translocation (14;18), and persistence of occult HCV lymphoid infection after treatment 98
Hepatitis C virus core protein expression in human B-cell lines does not significantly modify main proliferative and apoptosis pathways 97
HCV core protein expression in human B cell lines does not significantly modify proliferative and apoptosis pathways. 93
Analysis of HCV persistence in patients with sustained virological response 91
HCV core protein expression in human B cell lines does not significantly modify proliferative and apoptosis pathways 89
Combined presence of HCVRNA sequences and t(14;18) (q32;q21) translocation in PBMC from patients with chronic HCV infection 89
HCV core protein expression in human B cell lines does not significantly modify proliferative and apoptosis pathways 84
Alterazioni del sistema pPAF-AH/PAF in pazienti con infezione cronica da HCV 83
Hepatitis C virus lymphotropism and possible pathogenetic implications 80
Regression of t(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection 78
Relevance of inapparent coinfection by hepatitis B virus in alpha interferon-treated patients with hepatitis C virus chronic hepatitis 78
Regression of t(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 76
Interstitial lung fibrosis in patients with hepatitis C virus infection 75
Hepatitis C virus as a lymphotropic agent: evidence and pathogenetic implications 71
Behaviour of sustained responders to anti-HCV treatment: may HCV infection be eradicated? 71
Serum HCV-RNA and liver histologic findings in patients with long-term normal transaminases 70
Bcl-2 rearranged B cell clones in chronic HCV infection: a possible factor negatively influencing the virological response to treatment 70
Is t(14;18)(q32;q21) translocation a hallmark of HCV-related mixed cryoglobulinemia? 68
Is T(14;18)(q32;q21) translocation a hallmark of HCV-related mixed cryoglobulinemia? 67
Frequency of bcl-2 rearrangement in patients with mixed cryoglobulinemia and HCV-positive liver diseases 62
Regression of T(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 60
Efficacia del trattamento antivirale nell’indurre la regressione di cloni B cellulari alberganti la traslocazione t(14;18) nell’infezione cronica da virus C dell’epatite (HCV). 59
Prevalence of bcl-2 rearrangement in hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas. 57
Interferon alfa + Ribavirin (RIBA) therapy for chronic hepatitis C (CHC) patients non responders to interferon alfa monotherapy 53
Effect of antiviral treatment on the prevalence of BCL-2 recombination in HCV infected patients 52
Plasma PAF-AH biological activity decreases in patients with HCV chronic infection 50
Il virus dell'epatite C (HCV): l'infezione e la malattia 50
BCL-2 recombination and overexpression in HCV-related mixed cryoglobulinemia patients. 48
Bcl-2 Recombination and Overexpression in HCV-related Mixed Cryoglobulinemia Patients. 47
Infezione da HCV e disordini linfoproliferativi 47
HCV infection in B-cell non-Hodgkin’s lymphoma. 45
Hepatitis C virus as a lymphotropic agent: Evidence and pathogenetic implications 44
Regression of T(14;18) rearing B-cell clones following antiviral therapy in chronic HCV infection 42
Virological analysis of mixed infections by different HCV genotypes in patients with HCV related chronic liver disease 41
Prevalence of bcl-2 recombination in hepatitis C virus-related mixed cryoglobulinemia with or without complicating B-cell lymphoma. 40
Association between HCV infection and monoclonal gammopathy (MG): A putative role for genotype 2a? 40
Prevalenza della ricombinazione Bcl-2 in pazienti con crioglobulinemia mista HCV correlata complicata o meno da linfoma.. 39
Presence of BCL-2 rearranged B-cell clones in chronic HCV infection may negatively influence virological response to treatment 37
T(14;18) translocation amd BCL-2 overexpression in HCV infection: effects of Interferon and Ribavirin treatment 35
Prevalence of bcl-2 recombination in hepatitis C virus-related mixed cryoglobulinemia with or without complicating B-cell lymphoma. 35
Modifications of Plasma PAF-AH activity in Patients with Chronic HCV infection 34
Relevance of t(14;18) translocation in pathogenesis of HCV-related lymphoproliferative disorders. 34
Hepatitis-C virus-infection and monoclonal gammopathy (MG) - possible role of genotype 2A 32
Infezione delle cellule linfatiche da parte del virus C dell’epatite: fatti e controversie 30
Impact of liver transplantation in HCV-related lymphoproliferative disorders. 29
Ruolo dell’infezione da HCV nella crioglobulinemia mista e nel linfoma maligno a cellule B: analisi virologica ed implicazioni patogenetiche 28
Hepatitis C virus, Epstein-Barr virus and human Herpes virus-6 infection of lymphoid cell in B-cell non-Hodgkin’s lymphoma 27
Prevalence of monoclonal gammopathy (MG) in patients with chronic HCV infection 27
Manifestazioni extraepatiche dell’infezione da HCV 26
Prevalence of bcl-2 recombination in hepatitis C virus related mixed cryoglobulinemia with or without complicating B-cell lymphoma 25
Totale 3.445
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.636
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.636
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020385 0 0 0 46 46 57 53 58 43 37 37 8
2020/2021281 42 13 19 36 2 42 6 24 23 32 23 19
2021/2022336 2 45 5 16 10 6 9 19 13 5 68 138
2022/2023879 92 86 46 59 97 191 127 42 86 11 20 22
2023/2024281 13 39 63 20 32 47 10 34 7 0 6 10
2024/2025733 74 241 151 267 0 0 0 0 0 0 0 0
Totale 3.445